Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II pediatric study of FLUAD-H5N1 vaccine immunogenicity and safety
2007-002480-27Phase 2Completed
- Sponsor
- Novartis
- Start
- Jun 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Audenz in Avian Influenza (AI) (2 arms), sponsored by Novartis. Primary endpoints: Immunogenicity, Safety and tolerability after primary series and 1 more. Started Jun 2007; status: completed.
02
Drugs
Audenz
03
Conditions
Avian Influenza (AI)
Beyond the preview
Go deeper on 2007-002480-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002480-27.